Gene Symbol | Pearson Correlation Coefficient |
---|---|
USO1 | 0.922 |
MTDH | 0.921 |
AGPS | 0.921 |
PBRM1 | 0.919 |
NEMF | 0.918 |
MPP5 | 0.918 |
TRIP12 | 0.917 |
SEL1L | 0.915 |
RPS6KB1 | 0.914 |
UBA6 | 0.913 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.569 |
OR4F29 | -0.558 |
PLA2G5 | -0.296 |
HES5 | -0.268 |
MTRNR2L10 | -0.257 |
MTRNR2L6 | -0.25 |
PTGDR2 | -0.236 |
EYA2 | -0.236 |
PPP1R3G | -0.231 |
OR4F16 | -0.226 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene results in decreased expression of ITCH mRNA" | 20406850 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of ITCH mRNA | 21420995 |
D000082 | Acetaminophen | Acetaminophen affects the expression of ITCH mRNA | 17562736 |
D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in increased expression of ITCH mRNA | 21298039 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of ITCH mRNA | 21632981|2623829 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ITCH mRNA" | 19150397|2001819 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ITCH mRNA" | 26238291 |
C006780 | bisphenol A | bisphenol A results in decreased expression of ITCH mRNA | 25181051 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of ITCH mRNA | 15336504 |
C018475 | butyraldehyde | butyraldehyde results in decreased expression of ITCH mRNA | 26079696 |
D019327 | Copper Sulfate | Copper Sulfate results in increased expression of ITCH mRNA | 19549813 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of ITCH mRNA | 20106945|2556210 |
C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ITCH mRNA | 22079256 |
D011345 | Fenofibrate | Fenofibrate results in decreased expression of ITCH mRNA | 21318169 |
D011345 | Fenofibrate | PPARA protein affects the reaction [Fenofibrate results in decreased expression of ITCH mRNA] | 21318169 |
D005839 | Gentamicins | Gentamicins results in increased expression of ITCH mRNA | 22061828 |
C544151 | jinfukang | jinfukang results in decreased expression of ITCH mRNA | 27392435 |
C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of ITCH mRNA | 28001369 |
D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ITCH mRNA" | 26251327 |
D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ITCH mRNA" | 20188158 |
C025256 | nonylphenol | nonylphenol results in decreased expression of ITCH mRNA | 22982499 |
C025589 | ochratoxin A | ochratoxin A results in decreased expression of ITCH mRNA | 18417182 |
C568608 | PCI 5002 | [PCI 5002 co-treated with Zinc] results in increased expression of ITCH mRNA | 18593933 |
C046012 | pentanal | pentanal results in decreased expression of ITCH mRNA | 26079696 |
D010634 | Phenobarbital | Phenobarbital affects the expression of ITCH mRNA | 19159669 |
D010634 | Phenobarbital | Phenobarbital results in decreased expression of ITCH mRNA | 23091169 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of ITCH mRNA | 21318169 |
C006253 | pirinixic acid | PPARA protein affects the reaction [pirinixic acid results in decreased expression of ITCH mRNA] | 21318169 |
C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ITCH mRNA | 22079256 |
C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of ITCH mRNA | 22079256 |
D011374 | Progesterone | Progesterone results in increased expression of ITCH mRNA | 19690047 |
C009277 | sodium arsenate | sodium arsenate results in increased expression of ITCH mRNA | 21795629 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of ITCH mRNA | 27862939 |
D018038 | Sodium Selenite | Sodium Selenite results in decreased expression of ITCH mRNA | 18175754 |
C483909 | torcetrapib | torcetrapib results in increased expression of ITCH mRNA | 23228038 |
D014635 | Valproic Acid | Valproic Acid affects the expression of ITCH mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of ITCH mRNA | 28001369 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of ITCH gene | 25560391 |
D015032 | Zinc | [PCI 5002 co-treated with Zinc] results in increased expression of ITCH mRNA | 18593933 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004842 | ubiquitin-protein transferase activity | - | IDA | 17592138 |
GO:0004842 | ubiquitin-protein transferase activity | - | IMP | 24790097 |
GO:0004842 | ubiquitin-protein transferase activity | - | NAS | 10940313 |
GO:0005515 | protein binding | - | IPI | 9647693 12226085 14684745 15051726 15678106 16888620 16908849 17028573 17174309 17592138 19580544 20068034 20392206 20491914 20676133 20818436 20858735 22057290 22810586 23146885 24790097 25436413 |
GO:0016874 | ligase activity | - | IEA | - |
GO:0019787 | ubiquitin-like protein transferase activity | - | TAS | - |
GO:0043021 | ribonucleoprotein complex binding | - | IPI | 19881509 |
GO:0044389 | ubiquitin-like protein ligase binding | - | IPI | 24790097 |
GO:0045236 | CXCR chemokine receptor binding | - | IPI | 19116316 |
GO:0061630 | ubiquitin protein ligase activity | - | IBA | 21873635 |
GO:0061630 | ubiquitin protein ligase activity | - | IDA | 15678106 |
GO:0061630 | ubiquitin protein ligase activity | - | TAS | - |
GO:1990763 | arrestin family protein binding | - | IPI | 23886940 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000209 | protein polyubiquitination | - | IBA | 21873635 |
GO:0001558 | regulation of cell growth | - | NAS | 9462742 |
GO:0002669 | positive regulation of T cell anergy | - | IEA | - |
GO:0006511 | ubiquitin-dependent protein catabolic process | - | IDA | 15678106 |
GO:0006511 | ubiquitin-dependent protein catabolic process | - | NAS | 9462742 |
GO:0006915 | apoptotic process | - | IEA | - |
GO:0006954 | inflammatory response | - | NAS | 9462742 |
GO:0007219 | Notch signaling pathway | - | TAS | - |
GO:0016567 | protein ubiquitination | - | IBA | 21873635 |
GO:0016567 | protein ubiquitination | - | IDA | 17592138 25631046 |
GO:0016567 | protein ubiquitination | - | IMP | 24790097 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | - | ISS | - |
GO:0032480 | negative regulation of type I interferon production | - | TAS | - |
GO:0035519 | protein K29-linked ubiquitination | - | IBA | 21873635 |
GO:0035519 | protein K29-linked ubiquitination | - | IDA | 17028573 18628966 |
GO:0043066 | negative regulation of apoptotic process | - | IMP | 20068034 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | - | IBA | 21873635 |
GO:0045087 | innate immune response | - | IEA | - |
GO:0045732 | positive regulation of protein catabolic process | - | IBA | 21873635 |
GO:0045732 | positive regulation of protein catabolic process | - | IEA | - |
GO:0046329 | negative regulation of JNK cascade | - | ISS | - |
GO:0046642 | negative regulation of alpha-beta T cell proliferation | - | IEA | - |
GO:0046718 | viral entry into host cell | - | TAS | 12450395 |
GO:0050687 | negative regulation of defense response to virus | - | IMP | 19881509 |
GO:0051607 | defense response to virus | - | IEA | - |
GO:0051865 | protein autoubiquitination | - | IMP | 24790097 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | - | TAS | - |
GO:0070534 | protein K63-linked ubiquitination | - | IBA | 21873635 |
GO:0070534 | protein K63-linked ubiquitination | - | IDA | 18718448 19592251 |
GO:0070936 | protein K48-linked ubiquitination | - | IBA | 21873635 |
GO:0070936 | protein K48-linked ubiquitination | - | IDA | 19881509 |
GO:0090085 | regulation of protein deubiquitination | - | ISS | - |
GO:1902036 | regulation of hematopoietic stem cell differentiation | - | TAS | - |
GO:2000646 | positive regulation of receptor catabolic process | - | IMP | 24790097 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005654 | nucleoplasm | - | IDA | - |
GO:0005737 | cytoplasm | - | IBA | 21873635 |
GO:0005769 | early endosome | colocalizes_with | IDA | 24790097 |
GO:0005829 | cytosol | - | TAS | - |
GO:0005886 | plasma membrane | - | IDA | 14602072 |
GO:0005938 | cell cortex | - | IEA | - |
GO:0016020 | membrane | - | HDA | 19946888 |
GO:0031901 | early endosome membrane | - | IEA | - |
GO:0032991 | protein-containing complex | - | IDA | 24790097 |
GO:0043231 | intracellular membrane-bounded organelle | - | IDA | - |
GO:0070062 | extracellular exosome | - | HDA | 23533145 |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-1236394 | Signaling by ERBB4 | TAS |
R-HSA-1253288 | Downregulation of ERBB4 signaling | TAS |
R-HSA-1280218 | Adaptive Immune System | TAS |
R-HSA-157118 | Signaling by NOTCH | TAS |
R-HSA-157118 | Signaling by NOTCH | IEA |
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-162582 | Signal Transduction | IEA |
R-HSA-168249 | Innate Immune System | TAS |
R-HSA-168256 | Immune System | TAS |
R-HSA-168638 | NOD1/2 Signaling Pathway | TAS |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | TAS |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | TAS |
R-HSA-1980143 | Signaling by NOTCH1 | TAS |
R-HSA-1980143 | Signaling by NOTCH1 | IEA |
R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus | TAS |
R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus | IEA |
R-HSA-212436 | Generic Transcription Pathway | TAS |
R-HSA-5358351 | Signaling by Hedgehog | TAS |
R-HSA-5610780 | Degradation of GLI1 by the proteasome | TAS |
R-HSA-5610787 | Hedgehog 'off' state | TAS |
R-HSA-5632684 | Hedgehog 'on' state | TAS |
R-HSA-73857 | RNA Polymerase II Transcription | TAS |
R-HSA-74160 | Gene expression (Transcription) | TAS |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | TAS |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | TAS |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | TAS |
R-HSA-936440 | Negative regulators of DDX58/IFIH1 signaling | TAS |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | TAS |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
19538185 | Itch and scratching as predictors of time to clearance of psoriasis with narrow-band ultraviolet B therapy. (2009 Sep) | Evers AW | Br J Dermatol |
27162327 | Collybolide is a novel biased agonist of kappa-opioid receptors with potent antipruritic activity. (2016 May 24) | Gupta A | Proc Natl Acad Sci U S A |
22294496 | Prevalence and determinants of allergic diseases in a Congolese population. (2012 Jul-Aug) | Nyembue TD | Int Forum Allergy Rhinol |
24830002 | Clinical Aspects of Itch: Psoriasis (2014) | Reich A | - |
10768819 | Pathophysiology and treatment of psoriasis. (2000 Apr 1) | Peters BP | Am J Health Syst Pharm |
23868626 | [The possible uses of balneotherapy in treating chronic venous insufficiency of lower limbs]. (2013 May-Jun) | Petraccia L | Clin Ter |